Central serous chorioretinopathy following the BNT162b2 mRNA vaccine

BACKGROUND AND PURPOSE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has accelerated vaccine development. The BNT162b2 messenger RNA (mRNA) vaccine is being administered worldwide. The purpose of this case series is to report a possible association between the BNT162b2 mRNA vaccine a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanhart, J., Roditi, E., Wasser, L.M., Barhoum, W., Zadok, D., Brosh, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099405/
https://www.ncbi.nlm.nih.gov/pubmed/35577701
http://dx.doi.org/10.1016/j.jfo.2022.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099405/
https://www.ncbi.nlm.nih.gov/pubmed/35577701
http://dx.doi.org/10.1016/j.jfo.2022.01.006

Ejemplares similares